Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida’s KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida’s KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 15 2016

Full Issue

N.H. In David Vs. Goliath Fight Against Opioid-Makers

The state – without any outside assistance – has three lawyers working on an investigation around the marketing of the companies' painkillers. The pharmaceutical companies have 19. Media outlets also report on developments on the drug epidemic in Massachusetts, Louisiana and Pennsylvania.

One year after the state attorney general’s office filed subpoenas against five large drug companies to discover how addictive painkillers have been marketed in the state, the pharmaceutical giants have handed over nothing more than legal briefs. ... [Assistant Attorney General James] Boffetti’s three-person team is badly outnumbered by lawyers representing the pharmaceutical companies as they fight to get access to internal company documents. (Nilsen, 7/14)

People fighting addiction who get subsidized insurance will no longer have to pay for outpatient medication and counseling starting next year, a move officials hope will reverberate throughout the insurance market. The Massachusetts Health Connector, a state agency serving people who don’t obtain insurance through an employer, is requiring Connector insurers to eliminate all out-of-pocket costs for medication-assisted treatment that includes drugs such as methadone or Suboxone along with counseling. The Connector’s governing board approved the plan unanimously Thursday. The requirement applies only to health plans that come with federal and state subsidies, which together enroll 169,000 people, a small fraction of the 4.2 million Massachusetts residents who buy commercial insurance. (Freyer, 7/15)

Orleans Parish Coroner Dr. Jeffrey Rouse says he's pleased the city's homicide rate is down so far in 2016, but his office's resources are still being stretched to handle a sharp increase in the number of overdose deaths involving opioids. The coroner said there were 65 opioid deaths in New Orleans this year as of May 21, compared with just 47 homicides over the same period. (LaRose, 7/14)

Pennsylvania will open 20 centers around the state by fall to coordinate care for people addicted to opioids, the Wolf administration announced Thursday. The centers -- six of them in Southeastern Pennsylvania -- will not be new locations, but instead are existing organizations that will function as navigational hubs to coordinate a range of services for Medicaid patients. (Sapatkin, 7/15)

It’s a common scenario: Someone checks into a hospital for surgery or an illness and leaves with a prescription for an opioid painkiller, opening the door to long-term use and dependence. A recent study examined this pattern and found the prescriptions are used and renewed more often than you might imagine. ... The results, first published online in JAMA Internal Medicine in June, showed that 14.9 percent of the hospitalized [Medicare] beneficiaries filled a prescription for an opioid within a week after being discharged. Of those who filled the first prescription, 42.5 percent had another pharmacy claim for an opioid painkiller at least 90 days later. (Andrews, 7/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ